Dalteparin Sodium

Known as: Dalteparin Sodyum, Daltéparine sodique, Dalteparinum Natricum 
A drug used to prevent blood clots from forming or to treat blood clots that have formed in patients with cancer or other conditions. Dalteparin… (More)
National Institutes of Health

Topic mentions per year

Topic mentions per year

1993-2017
02419932017

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2011
2011
This study evaluated whether heparin administration could affect IVF outcome. A total of 172 women, aged <40years, without… (More)
  • figure 1
  • table 1
  • table 2
Is this relevant?
2010
2010
Tumors are angiogenesis dependent and vascular endothelial growth factor-A (VEGF-A), a heparin-binding protein, is a key… (More)
  • table 1
  • table 2
  • table 3
Is this relevant?
2008
2008
BACKGROUND Use of low-molecular-weight heparins is avoided in patients with renal insufficiency because of concerns about an… (More)
  • table 1
  • table 2
  • table 3
Is this relevant?
2005
2005
BACKGROUND We were concerned that a fixed rather than a weight-based dosing regimen of dalteparin sodium to prevent venous… (More)
Is this relevant?
Highly Cited
2004
Highly Cited
2004
Methods: We studied 650 consecutive patients with a mechanical heart valve, chronic atrial fibrillation, or embolic stroke who… (More)
  • table 1
  • table 2
  • table 3
  • table 4
  • table 5
Is this relevant?
2003
2003
BACKGROUND Sensitization of Kupffer cells (KC) to lipopolysaccharide (LPS) and overproduction of tumor necrosis factor (TNF… (More)
Is this relevant?
2002
2002
PURPOSE To evaluate the effect of standard chemotherapeutic regimens on the hemostatic profile of patients with breast and lung… (More)
Is this relevant?
2000
2000
BACKGROUND No randomized trials have directly evaluated the need for extended out-of-hospital thromboprophylaxis for patients who… (More)
Is this relevant?
Highly Cited
2000
Highly Cited
2000
BACKGROUND Based on the current understanding that venous thrombosis starts perioperatively, administration of just-in-time low… (More)
Is this relevant?
Highly Cited
1998
Highly Cited
1998
BACKGROUND The outpatient treatment of patients with deep vein thrombosis and pulmonary embolism using low-molecular-weight… (More)
  • table 1
  • table 2
Is this relevant?